High risk factors of pancreatic carcinoma

Abstract

Over the past decades, cancer has become one of the toughest challenges for health professionals. The epidemiologists are increasingly directing their research efforts on various malignant tumor worldwide. Of note, incidence of cancers is on the rise more quickly in developed countries. Indeed, great endeavors have to be made in the control of the life-threatening disease. As we know it, pancreatic cancer (PC) is a malignant disease with the worst prognosis. While little is known about the etiology of the PC and measures to prevent the condition, so far, a number of risk factors have been identified. Genetic factors, pre-malignant lesions, predisposing diseases and exogenous factors have been found to be linked to PC. Genetic susceptibility was observed in 10% of PC cases, including inherited PC syndromes and familial PC. However, in the remaining 90%, their PC might be caused by genetic factors in combination with environmental factors. Nonetheless, the exact mechanism of the two kinds of factors, endogenous and exogenous, working together to cause PC remains poorly understood. The fact that most pancreatic neoplasms are diagnosed at an incurable stage of the disease highlights the need to identify risk factors and to understand their contribution to carcinogenesis. This article reviews the high risk factors contributing to the development of PC, to provide information for clinicians and epidemiologists.

Keywords

high risk factors / pancreatic cancer / treatment / epidemiology / pathogenesis / etiology

References

[1] American Cancer Society. Cancer facts & figures. The Society, 2014(www.cancer.org)

[2] AndersonKE, MackTM, SilvermanDT. Cancer of the pancreas. Cancer epidemiology and prevention, 20063New York Oxford, University Press, 721-763

[3] SeiceanA, SeiceanT. Risk factors in pancreatic cancer, 2012

[4] Mayerle J, Simon P, Lerch MM. Pancreatitis and exogenous risk factors for pancreatic cancer. Exocrine pancreas, cancer. 30. Online, website: (http://www.cancer.org/cancer/pancreaticcancer/detailedg uide/pancreatic-cancer-risk-factors)

[5] GhadirianP, BoyleP, SimardA, et al. . Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol, 1991, 10(3-4): 183-196 PMID: 1787333

[6] FalkRT, PickleLW, FonthamET, et al. . Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol, 1988, 128(2): 324-336 PMID: 3394699

[7] FernandezE, La VecchiaC, D'AvanzoB, et al. . Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 1994, 3(3): 209-212 PMID: 8019368

[8] SilvermanDT, SchiffmanM, EverhartJ, et al. . Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Brit J Cancer, 1999, 80(11): 1830 PMID: 10468306 PMCID: 2363127

[9] GoldsteinAM, FraserMC, StruewingJP, et al. . Increased risk of pancreatic cancer in melanoma-prone kindreds with p16 INK4 mutations. N England J Med, 1995, 333(15): 970-975

[10] WhelanAJ, BartschD, GoodfellowPJ. A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N England J Med, 1995, 333(15): 975-977

[11] Borg, SandbergT, NilssonK, et al. . High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst, 2000, 92(15): 1260-1266 PMID: 10922411

[12] GoldsteinAM, StruewingJP, ChidambaramA, et al. . Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst, 2000, 92(12): 1006-1010 PMID: 10861313

[13] VasenHF, GruisNA, FrantsRR, et al. . Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer, 2000, 87(6): 809-811 PMID: 10956390

[14] de SnooFA, BishopDT, BergmanW, et al. . Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res, 2008, 14(21): 7151-7157 PMID: 18981015

[15] BhutaniMS, ThosaniN, SuzukiR, et al. . Pancreatic cancer screening: what we do and do not know. Clin Gastroenterol Hepatol, 2013, 6(11): 731-733

[16] McWilliamsRR, BamletWR, de AndradeM, et al. . Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev, 2009, 18(9): 2549-2552 PMID: 19690177 PMCID: 2742574

[17] GhiorzoP, CiottiP, MantelliM, et al. . Characterization of ligurian melanoma families and risk of occurrence of other neoplasia. Int J Cancer, 1999, 83(4): 441-448 PMID: 10508477

[18] CiottiP, StriginiP, Bianchi-ScarràG, et al. . Familial melanoma and pancreatic cancer. N Engl J Med, 1996, 334: 469-470 PMID: 8552158

[19] BartschDK, Sina-FreyM, LangS, et al. . CDKN2A germline mutations in familial pancreatic cancer. Ann Surg, 2002, 236(6): 730 PMID: 12454511 PMCID: 1422639

[20] MoskalukCA, HrubanRH, LietmanA, et al. . Novel germline p16 [sup] INK4 allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Hum Mutat, 1998, 12(1): 70 PMID: 10627132

[21] MoorePS, ZamboniG, FalconiM, et al. . A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. Human Mutation, 2000, 16(5): 447 PMID: 11058911

[22] VasenHF, WasserM, van MilA, et al. . Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology, 2011, 140(3): 850-856 PMID: 21129377

[23] BeggsAD, LatchfordAR, VasenHF, et al. . Peutz–Jeghers syndrome: a systematic review and recommendations for management. Gut, 2010, 59(7): 975-986 PMID: 20581245

[24] Van LierMG, WestermanAM, WagnerAY, et al. . High cancer risk and increased mortality in patients with Peutz–Jeghers syndrome. Gut, 2011, 60(2): 141-147 PMID: 21205875

[25] GiardielloFM, WelshSB, HamiltonSR, et al. . Increased risk of cancer in the Peutz–Jeghers syndrome. N Engl J Med, 1987, 316(24): 1511-1514 PMID: 3587280

[26] GiardielloFM, BrensingerJD, TersmetteAC, et al. . Very high risk of cancer in familial Peutz–Jeghers syndrome. Gastroenterology, 2000, 119(6): 1447-1453 PMID: 11113065

[27] HearleN, SchumacherV, MenkoFH, et al. . Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res, 2006, 12(10): 3209-3215 PMID: 16707622

[28] MehenniH, RestaN, ParkJG, et al. . Cancer risks in LKB1 germline mutation carriers. Gut, 2006, 55(7): 984-990 PMID: 16407375 PMCID: 1856321

[29] YouYN, WolffBG, BoardmanLA, et al. . Peutz-Jeghers syndrome: a study of long-term surgical morbidity and causes of mortality. Fam Cancer, 2010, 9(4): 609-616 PMID: 20571886

[30] KorsseSE, HarinckF, van LierMG, et al. . Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance. J Med Genet, 2013, 50(1): 59-64 PMID: 23240097

[31] LowenfelsAB, MaisonneuveP, Di MagnoEPY, et al. . Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst, 1997, 89(6): 442-446 PMID: 9091646

[32] GorryMC, GabbaizedehD, FureyW, et al. . Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology, 1997, 113(4): 1063-1068 PMID: 9322498

[33] WhitcombDC. Hereditary pancreatitis: new insights into acute and chronic pancreatitis. Gut, 1999, 45(3): 317-322 PMID: 10446089 PMCID: 1727629

[34] LowenfelsAB, MaisonneuveP, CavalliniG, et al. . Pancreatitis and the risk of pancreatic cancer. N Engl J Med, 1993, 328(20): 1433-1437 PMID: 8479461

[35] WhitcombDC, ApplebaumS, MartinSP. Hereditary pancreatitis and pancreatic carcinoma. Ann N Y Academy Sci, 1999, 880(1): 201-209

[36] ReboursV, Boutron-RuaultMC, SchneeM, et al. . Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. AJG, 2008, 103(1): 111-119 PMID: 18184119

[37] LowenfelsAB, MaisonneuveP, WhitcombDC, et al. . Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA, 2001, 286(2): 169-170 PMID: 11448279

[38] GreerJB, ZarnescuNO, WhitcombDC. Hereditary Pancreatitis and Pancreatic Cancer, 200881-96

[39] LowenfelsAB, MaisonneuveP, LankischPG, et al. . Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol Clin North Am, 1999, 28(3): 673-685 PMID: 10503143

[40] HahnSA, GreenhalfB, EllisI, et al. . BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst, 2003, 95(3): 214-221 PMID: 12569143

[41] HowesN, NeoptolemosJP. Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut, 2002, 1(6): 765-766

[42] HowesN, WongT, GreenhalfW, et al. . Pancreatic cancer risk in hereditary pancreatitis in Europe. Digestion, 2000, 61(61): 70

[43] WittH, LuckW, HenniesHC, et al. . Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet, 2000, 25(2): 213-216 PMID: 10835640

[44] GreerJB, WhitcombDC, BrandRE. Genetic predisposition to pancreatic cancer: a brief review. AJG, 2007, 102(11): 2564-2569 PMID: 17958761

[45] TuliniusH, OlafsdottirGH, SigvaldasonH, et al. . Neoplastic diseases in families of breast cancer patients. J Med Genet, 1994, 31(8): 618-821 PMID: 7815419 PMCID: 1050023

[46] PhelanCM, LancasterJM, ToninP, et al. . Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families. Nat Genet, 1996, 13(1): 120-122 PMID: 8673090

[47] SimardJ, ToninP, DurocherF, et al. . Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet, 1994, 8(4): 392-398 PMID: 7894492

[48] FordD, EastonDF, StrattonM, et al. . Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet, 1998, 62(3): 676-689 PMID: 9497246 PMCID: 1376944

[49] Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Nat Cancer Inst, 1999, 91(15): 1310-1316

[50] HahnSA, GreenhalfB, EllisI, et al. . BRCA2 germline mutations in familial pancreatic carcinoma. J Nat Cancer Inst, 2003, 95(3): 214-221 PMID: 12569143

[51] ThompsonD, EastonDF. Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers. J Nat Cancer Inst, 2002, 94(18): 1358-1365 PMID: 12237281

[52] RischHA, McLaughlinJR, ColeDE, et al. . Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet, 2001, 68(3): 700-710 PMID: 11179017 PMCID: 1274482

[53] BoderE. Ataxia-telangiectasia: an overview. Kroc Foundation, 1985, 19: 1-63

[54] ReimanA, SrinivasanV, BaroneG, et al. . Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Brit J Cancer, 2011, 105(4): 586-591 PMID: 21792198 PMCID: 3170966

[55] RobertsNJ, JiaoY, YuJ, et al. . ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov, 2012, 2(1): 41-46 PMID: 22585167

[56] LiA, SwiftM. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A–T patients. Am J Med Genet, 2000, 92(3): 170-177 PMID: 10817650

[57] RenwickA, ThompsonD, SealS, et al. . ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet, 2006, 38(8): 873-875 PMID: 16832357

[58] LynchHT, de la ChapelleA. Hereditary colorectal cancer. N Engl J Med, 2003, 348(10): 919-932 PMID: 12621137

[59] WatsonP, VasenHF, MecklinJP, et al. . The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int Cancer, 2008, 123(2): 444-449

[60] WinAK, YoungJP, LindorNM, et al. . Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol, 2012, 30(9): 958-964 PMID: 22331944 PMCID: 3341109

[61] GiardielloFM, OfferhausGJ, LeeDH, et al. . Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut, 1993, 34(10): 1394-1396 PMID: 8244108 PMCID: 1374548

[62] BartschDK. Familial pancreatic cancer. Brit J Surg, 2003, 90(4): 386-397 PMID: 12673738

[63] HrubanRH, PetersenGM, GogginsM, et al. . Familial pancreatic cancer. Ann Oncol, 1999, 10(4): S69-573

[64] KleinAP, BruneKA, PetersenGM, et al. . Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res, 2004, 64(7): 2634-2638 PMID: 15059921

[65] KleinAP, BorgesM, GriffithM, et al. . Absence of deleterious palladin mutations in patients with familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 2009, 18(4): 1328-1330 PMID: 19336541 PMCID: 2824557

[66] TersmetteAC, PetersenGM, OfferhausK, et al. . Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res, 2001, 7(3): 738-744 PMID: 11297271

[67] SilvermanDT, DunnJA, HooverRN, et al. . Cigarette smoking and pancreas cancer: A case control study based on direct interviews. J Nat Cancer Inst, 1994, 86(20): 1510-1516 PMID: 7932805

[68] GoldEB, GoldinSB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin North Am, 1998, 1: 67-91

[69] RulyakSJ, LowenfelsAB, MaisonneuveP, et al. . Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology, 2003, 124(5): 1292-1299 PMID: 12730869

[70] MurphyKM, BruneKA, GriffinC, et al. . Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res, 2002, 62(13): 3789-3793 PMID: 12097290

[71] WhiteK, HeldKR, WeberBH. A BRCA2 germline mutation in familial pancreatic carcinoma. Int J Cancer, 2001, 91(5): 742-744 PMID: 11267991

[72] WolpinBM, ChanAT, HartgeP, et al. . ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 2009, 101(6): 424-431 PMID: 19276450 PMCID: 2657095

[73] WolpinBM, KraftP, GrossM, et al. . Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res, 2010, 70(3): 1015-1023 PMID: 20103627 PMCID: 2943735

[74] GreerJB, YazerMH, RavalJS, et al. . Significant association between ABO blood group and pancreatic cancer. WJG, 2010, 16(44): 5588-5591 PMID: 21105191 PMCID: 2992676

[75] AnneseV, MinerviniM, GabbrielliA, et al. . ABO blood groups and cancer of the pancreas. Int J Pancreatol, 1990, 6(2): 81-88 PMID: 2230362

[76] LüttgesJ, KlöppelG. Precancerous conditions of pancreatic carcinoma. J Hepatol Bil Pan Surg, 2000, 7(6): 568-574

[77] AppleSK, HechtJR, LewinDN, et al. . Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. Human Pathol, 1999, 30(2): 123-129

[78] Gold EB, Cameron JL. Chronic pancreatitis and pancreatic cancer. N Engl J Med, 328(20): 1485-486

[79] FernandezE, La VecchiaC, PortaM, et al. . Pancreatitis and the risk of pancreatic cancer. Pancreas, 1995, 11(2): 185-189 PMID: 7479677

[80] RaimondiS, LowenfelsAB, Morselli-LabateAM, et al. . Pancreatic cancer in chronic pancreatitis, aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol, 2010, 24(3): 349-358 PMID: 20510834

[81] CamaraSN, RamdanyS, WangCY, et al. . Etiology, pathology, diagnosis, management and prognosis of chronic pancreatitis in Chinese population. A retrospective study. J Huazhong Univ Sci Technol Med Sci, 2015, 35(3): 384-389 PMID: 26072078

[82] MaisonneuveP, LowenfelsAB. Chronic pancreatitis and pancreatic cancer. Digest Dis, 2002, 20(1): 32-37

[83] MalkaD, HammelP, MaireF, et al. . Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut, 2002, 51(6): 849-852 PMID: 12427788 PMCID: 1773474

[84] LowenfelsAB, MaisonneuveP, CavalliniG. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med, 1993, 328(20): 1433-1437 PMID: 8479461

[85] HowesN, LerchMM, GreenhalfW, et al. . Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol, 2004, 2(3): 252-261 PMID: 15017610

[86] BarmanKK, PremalathaG, MohanV. Tropical chronic pancreatitis. Postgrad Med J, 2003, 79(937): 606-615 PMID: 14654569 PMCID: 1742869

[87] WhitcombDC. Genetics and alcohol: a lethal combination in pancreatic disease. Alcohol Clin Exp Res, 2011, 35(5): 838-842 PMID: 21303381

[88] LowenfelsAB, MaisonneuveP. Epidemiologic and etiologic factors of pancreatic cancer. Hematol Oncol Clin North Am, 2002, 16(1): 1-16 PMID: 12063821

[89] EvansJD, MortonDG, NeoptolemosJP. Chronic pancreatitis and pancreatic carcinoma. Postgrad Med J, 1997, 73(863): 543-548 PMID: 9373592 PMCID: 2431435

[90] BatabyalP, Vander HoornS, ChristophiC, et al. . Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol, 2014, 21(7): 2453-2462 PMID: 24609291

[91] LiaoKF, LaiSW, LiCI, et al. . Diabetes mellitus correlates with increased risk of pancreatic cancer: A population-based cohort study in Taiwan. J Gastroenterol Hepatol, 2012, 27(4): 709-713 PMID: 21929650

[92] EverhartJ, WrightD. Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. JAMA, 1995, 273(20): 1605-1609 PMID: 7745774

[93] HuxleyR, Ansary-MoghaddamA, De GonzálezAB, et al. . Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Brit J Cancer, 2005, 92(11): 2076-2083 PMID: 15886696 PMCID: 2361795

[94] PannalaR, LeirnessJB, BamletWR, et al. . Prevalence and clinical profile of pancreatic cancer–associated diabetes mellitus. Gastroenterology, 2008, 134(4): 981-987 PMID: 18395079 PMCID: 2323514

[95] BosettiC, RosatoV, LiD, et al. . Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Ann Oncol, 2014, 25(10): 2065-2072 PMID: 25057164 PMCID: 4176453

[96] PezzilliR, FabbriD, ImbrognoA. Pancreatic ductal adenocarcinoma screening: New perspectives. WJG, 2012, 18(36): 4973 PMID: 23049204 PMCID: 3460322

[97] De MesquitaHB, MaisonneuveP, MoermanCJ, et al. . Aspects of medical history and exocrine carcinoma of the pancreas: A population-based case-control study in The Netherlands. Int J Cancer, 1992, 52(1): 17-23

[98] GulloL, PezzilliR, Morselli-LabateAM. Diabetes and the risk of pancreatic cancer. N Engl J Med, 1994, 331(2): 81-84 PMID: 8208269

[99] FryeJN, InderWJ, DobbsBR, et al. . Pancreatic cancer and diabetes: Is there a relationship? A case controlled study. Aust N Z J Surg, 2000, 70(10): 722-724 PMID: 11021485

[100] TalaminiG, FalconiM, BassiC, et al. . Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis. Pancreas, 2001, 23(4): 364-367 PMID: 11668204

[101] EgawaN, TuY, SanakaM, et al. . Family history of diabetes and pancreatic cancer. Pancreas, 2005, 30(1): 15-19 PMID: 15632694

[102] WangF, GuptaS, HollyEA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev, 2006, 15(8): 14581-14584

[103] GuptaS, VittinghoffE, BertenthalD, et al. . New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol, 2006, 4(11): 1366-1372 PMID: 16945591

[104] ChariST, LeibsonCL, RabeKG, et al. . Pancreatic cancer–associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology, 2008, 134(1): 95-101 PMID: 18061176

[105] KuangTT, JinDY, WangDS, et al. . Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China. J Digest Dis, 2009, 10(1): 26-29

[106] MaisonneuveP, LowenfelsAB, Bueno-de-MesquitaHB, et al. . Past medical history and pancreatic cancer risk: results from a multicenter case-control study. Ann Epidemiol, 2010, 20(2): 92-98 PMID: 20123159

[107] OlsonSH, ChouJF, LudwigE, et al. . Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer, 2010, 127(10): 2412-1419 PMID: 20143395

[108] ElenaJW, SteplowskiE, YuK, et al. . Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control, 2013, 24(1): 13-25 PMID: 23112111

[109] PierceBL, AustinMA, AhsanH, et al. . Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control, 2011, 22(6): 877-883 PMID: 21445555

[110] BlotWJ, FraumeniJF, StoneBJ. Geographic correlates of pancreas cancer in the United States. Cancer, 1978, 42(1): 373-380 PMID: 667808

[111] MizunoS, WatanabeS, NakamuraK, et al. . A multi-institute case-control study on the risk factors of developing pancreatic cancer. Jap J Clin Oncol, 1992, 22(4): 286-291

[112] ShibataA, MackTM, Paganini HillA, et al. . A prospective study of pancreatic cancer in the elderly. Int J Cancer, 1994, 58(1): 46-49 PMID: 8014014

[113] SilvermanDT. Risk factors for pancreatic cancer: A case-control study based on direct interviews. Teratogen Carc Mut, 2001, 21(1): 7-25

[114] LuoJ, IwasakiM, InoueM, et al. . Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan–the JPHC study. Cancer Causes Control, 2007, 18(6): 603-612 PMID: 17401636

[115] LipworthL, ZucchettoA, BosettiC, et al. . Diabetes mellitus, other medical conditions and pancreatic cancer: a case-control study. Diab Met Res Rev, 2011, 27(3): 255-261

[116] ChangCH, TohS, LinJW, et al. . Cancer risk associated with insulin glargine among adult type 2 diabetes patients–a nationwide cohort study. PLoS One, 2011, 6(6): e21368 PMID: 21738645 PMCID: 3124499

[117] Stolzenberg-SolomonRZ, GraubardBI, ChariS, et al. . Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA, 2005, 294(22): 2872-2878 PMID: 16352795

[118] GapsturSM, GannPH, LoweW, LiuK, et al. . Abnormal glucose metabolism and pancreatic cancer mortality. JAMA, 2000, 283(19): 2552-2558 PMID: 10815119

[119] LiD, JiaoL, LiY, et al. . Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis, 2005, 27(1): 103-111 PMID: 15987714 PMCID: 1350610

[120] AuneD, GreenwoodDC, ChanDS, et al. . Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose–response meta-analysis of prospective studies. Ann Oncol, 2011, 23(4): 843-852 PMID: 21890910

[121] O'RorkeMA, CantwellMM, CardwellCR, et al. . Can physical activity modulate pancreatic cancer risk? a systematic review and meta-analysis. Inter J Cancer, 2010, 126(12): 2957-2968

[122] MichaudDS, GiovannucciE, WillettWC, et al. . Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA, 2001, 286(8): 921-929 PMID: 11509056

[123] ParkinDM, BoydL. Cancers attributable to overweight and obesity in the UK in 2010. Brit J Cancer, 2011, 105: S34-S37 PMID: 22158318 PMCID: 3252060

[124] BosettiC, LucenteforteE, SilvermanDT, et al. . Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol, 2012, 23(7): 1880-1888 PMID: 22104574

[125] FuchsCS, ColditzGA, StampferMJ, et al. . A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med, 1996, 156(19): 2255-2260 PMID: 8885826

[126] MichaudDS. Epidemiology of pancreatic cancer. Minerva Chir, 2004, 59(2): 99-111 PMID: 15238885

[127] LynchSM, VrielingA, LubinJH, et al. . Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol, 2009, 170(4): 403-413 PMID: 19561064 PMCID: 2733861

[128] LinY, TamakoshiA, KawamuraT, et al. . A prospective cohort study of cigarette smoking and pancreatic cancer in Japan. Cancer Causes Control, 2002, 13(3): 249-254 PMID: 12020106

[129] AkibaS, HirayamaT. Cigarette smoking and cancer mortality risk in Japanese men and women—results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect, 1990, 87: 19 PMID: 2269225 PMCID: 1567850

[130] IodiceS, GandiniS, MaisonneuveP, et al. . Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbeck's Arch Surg, 2008, 393(4): 535-545

[131] ZhengW, McLaughlinJK, GridleyG, et al. . A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control, 1993, 4(5): 477-482 PMID: 8218880

[132] VilleneuvePJ, JohnsonKC, MaoY, et al. . Environmental tobacco smoke and the risk of pancreatic cancer: findings from a Canadian population-based case-control study. Can J Public Health, 2004, 95(1): 32-37 PMID: 14768739

[133] ArslanAA, HelzlsouerKJ, KooperbergC, et al. . Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Internal Med, 2010, 170(9): 791-802

[134] WeiderpassE, PartanenT, KaaksR, et al. . Occurrence, trends and environmental etiology of pancreatic cancer. Scand J Work Env Health, 1998, 24(3): 165-174

[135] de GonzalezAB, SweetlandS, SpencerE. A meta-analysis of obesity and the risk of pancreatic cancer. Brit J Cancer, 2003, 89(3): 519-523 PMCID: 2394383

[136] LarssonSC, PermertJ, HåkanssonN, et al. . Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Brit J Cancer, 2005, 93(11): 1310-1315 PMID: 16288300 PMCID: 2361517

[137] LiD, MorrisJS, LiuJ, et al. . Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA, 2009, 301(24): 2553-2562 PMID: 19549972 PMCID: 2760963

[138] LarssonSC, OrsiniN, WolkA. Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int J Cancer, 2007, 120(9): 1993-1998 PMID: 17266034

[139] GenkingerJM, SpiegelmanD, AndersonKE, et al. . A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer, 2011, 129(7): 1708-1717 PMID: 21105029 PMCID: 3073156

[140] CoughlinSS, CalleEE, PatelAV, et al. . Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control, 2000, 11(10): 915-923 PMID: 11142526

[141] BurneyPG, ComstockGW, MorrisJS. Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutrit, 1989, 49(5): 895-900 PMID: 2718925

[142] NkondjockA, GhadirianP, JohnsonKC, et al. . Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr, 2005, 135(3): 592-597 PMID: 15735099

[143] RischHA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Nat Cancer Inst, 2003, 95(13): 948-960 PMID: 12837831

[144] NöthlingsU, WilkensLR, MurphySP, et al. . Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Nat Cancer Inst, 2005, 97(19): 1458-1465 PMID: 16204695

[145] ThiébautAC, JiaoL, SilvermanDT, et al. . Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst, 2009, 101(4): 1001-1011 PMID: 19561318 PMCID: 2724851

[146] EkbomA, DavidH. Pancreatic cancer. Textbook of cancer epidemiology, 2002233-247

[147] MichaudDS, GiovannucciE, WillettWC, et al. . Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study. A J Epidemiol, 2003, 157(12): 1115-1125

[148] MichaudDS, SkinnerHG, WuK, et al. . Dietary patterns and pancreatic cancer risk in men and women. J Nat Cancer Inst, 2005, 97(7): 518-524 PMID: 15812077

[149] JiaoL, FloodA, SubarAF, et al. . Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study. Cancer Epidemiol Biomarkers Prev, 2009, 18(4): 1144-1151 PMID: 19336549 PMCID: 2687095

[150] HoweG, GhadirianRP, de MesquitaHB, et al. . A collaborative case-control study of nutrient intake and pancreatic cancer within the search programme. Int J Cancer, 1992, 51: 365-372 PMID: 1317361

[151] Stolzenberg-SolomonRZ, PietinenP, TaylorPR, et al. . Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol, 2002, 155(9): 783-792 PMID: 11978580

[152] SkinnerHG, MichaudDS, GiovannucciE, et al. . Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev, 2006, 15(9): 1688-1695 PMID: 16985031

[153] GrantWB. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer, 2002, 94(6): 1867-1875 PMID: 11920550

[154] GuytonKZ, KenslerTW, PosnerGH. Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutrit Rev, 2003, 61(7): 227-238 PMID: 12918875

[155] Stolzenberg-SolomonRZ, JacobsEJ, ArslanAA, et al. . Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol, 2010, 172(1): 81-93 PMID: 20562185 PMCID: 2892543

[156] Stolzenberg-SolomonRZ, HayesRB, HorstRL, et al. . Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res, 2009, 69(4): 1439-1447 PMID: 19208842 PMCID: 3052200

[157] HassanMM, BondyML, WolffRA, et al. . Risk factors for pancreatic cancer: case-control study. AJG, 2007, 102(12): 2696-2707 PMID: 17764494 PMCID: 2423805

[158] FarrowDC, DavisS. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer, 1990, 45(5): 816-820 PMID: 2335385

[159] TalaminiG, BassiC, FalconiM, et al. . Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Digest Dis Sci, 1999, 44(7): 1303-1311 PMID: 10489910

[160] LinY, TamakoshiA, KawamuraT, et al. . Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk. Int J Cancer, 2002, 99(5): 742-746 PMID: 12115510

[161] MichaudDS, GiovannucciE, WillettWC, et al. . Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev, 2001, 10(5): 429-437 PMID: 11352851

[162] WeisburgerJH. Comments on the history and importance of aromatic and heterocyclic amines in public health. Mutation Res Fund Mol Mech Mut, 2002, 506-507: 9-20